Trials | mAb

222,071 trials tracked, sourced from ClinicalTrials.gov and manual curation.

Trial Home - Preamble

This page summarizes information about the clinical trials that support investigation of both approved and experimental medicines. This information includes information about the interventions and their sponsoring organizations. Note that these data are derived from ClinicalTrials.gov, with information corrected and disambiguated to convey more accurate detail about these trials. Phase 4 trials are currently excluded on this page by default, as this data will be analyzed separately at a later date.

Experimental drugs in trials

2,857

Approved drugs in trials

154

Marketed drugs in trials

0

Phase 1

2,768 drugs · 2,378 orgs

Top drugs

Top sponsors

Phase 2

1,680 drugs · 3,180 orgs

Top drugs

Top sponsors

Phase 3

576 drugs · 1,622 orgs

Top drugs

Top sponsors

Clinical trial trends

All Trials by Phase

Loading chart…

Experimental APIs by Year

Loading chart…

First Trial for each API by Phase

Loading chart…

Browse all trials

NCT IDPhaseTypeStart dateEnrollment
NCT05002465N/AExpanded Access
NCT05014724N/AExpanded Access
NCT05022901N/AExpanded Access
NCT05028166N/AExpanded Access
NCT05041036N/AExpanded Access
NCT05047328N/AExpanded Access
NCT05064306N/AExpanded Access
NCT05086094N/AExpanded Access
NCT05095116N/AExpanded Access
NCT05131438N/AExpanded Access
NCT05151679N/AExpanded Access
NCT05154851N/AExpanded Access
NCT05157165N/AExpanded Access
NCT05162443N/AExpanded Access
NCT05161598N/AExpanded Access
NCT05164250N/AExpanded Access
NCT07164482N/AExpanded Access
NCT07216378N/AExpanded Access
NCT07218224N/AExpanded Access
NCT07238062N/AExpanded Access
NCT07262970N/AExpanded Access
NCT07301450N/AExpanded Access
NCT07310277N/AExpanded Access
NCT03395769N/AExpanded Access
NCT03196934N/AExpanded Access
Page 1 of 8,883